Korean J Women Health Nurs.  2021 Jun;27(2):64-68. 10.4069/kjwhn.2021.05.31.

Practical issues and research trends of oncofertility in gynecologic cancer

• Park JY

• KMID: 2517564
• DOI: http://doi.org/10.4069/kjwhn.2021.05.31

Abstract

In recent years, there has been a greater impetus toward preserving fertility in young women with gynecologic cancer. This is related to the increasing incidence of gynecologic cancer in young women and to the social phenomenon in which women, on average, are getting married and having their first child at an older age. For women with early gynecologic cancer, treatment strategies can be undertaken to preserve the uterus and part of the ovaries, which can be used to preserve fertility. For women with advanced gynecologic cancer, treatment strategies using assisted reproductive technology are the main option to preserve fertility. Young women with gynecologic cancer who want to preserve fertility should be counseled thoroughly regarding treatment options that allow fertility preservation before commencing anti-cancer treatment. This article describes various methods for preserving fertility and examines recent research trends related to young women with gynecologic cancer.

Keyword

Cervical cancer; Endometrial Cancer; Gynecologic Cancer; Oncofertility; Ovarian Cancer

Reference

References

1. Hong S, Won YJ, Lee JJ, Jung KW, Kong HJ, Im JS, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2018. Cancer Res Treat. 2021; 53(2):301–315. https://doi.org/10.4143/crt.2021.291.

2. Lim MC, Won YJ, Ko MJ, Kim M, Shim SH, Suh DH, et al. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015. J Gynecol Oncol. 2019; 30(1):e38. https://doi.org/10.3802/jgo.2019.30.e38.

3. Repetto R. Economic equality and fertility in developing countries. New York: RFF Press;2013.

4. Costales A, Michener C, Escobar-Rodriguez PF. Radical trachelectomy for early stage cervical cancer. Curr Treat Options Oncol. 2018; 19(12):75. https://doi.org/10.1007/s11864-018-0591-4.

5. Dargent D, Martin X, Sacchetoni A, Mathevet P. Laparoscopic vaginal radical trachelectomy: a treatment to preserve the fertility of cervical carcinoma patients. Cancer. 2000; 88(8):1877–1882.

6. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: cervical cancer, version 1. 2021 [Internet]. Plymouth Meeting (PA): Author; 2020 [cited 2021 Jun 8]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf.

7. Dargent D. La trachélectomie élargie: une opération permettant de préserver la fertilité des femmes jeunes atteintes de cancer invasif du col utérin [Radical trachelectomy: an operation that preserves the fertility of young women with invasive cervical cancer]. Bull Acad Natl Med. 2001; 185(7):1295–1306.

8. Abu-Rustum NR, Neubauer N, Sonoda Y, Park KJ, Gemignan M, Alektiar KM, et al. Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. Gynecol Oncol. 2008; 111(2):261–264. https://doi.org/10.1016/j.ygyno.2008.07.002.

9. Park JY, Joo WD, Chang SJ, Kim DY, Kim JH, Kim YM, et al. Long-term outcomes after fertility-sparing laparoscopic radical trachelectomy in young women with early-stage cervical cancer: an Asan Gynecologic Cancer Group (AGCG) study. J Surg Oncol. 2014; 110(3):252–257. https://doi.org/10.1002/jso.23631.

10. Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, et al. Reproductive outcomes after laparoscopic radical trachelectomy for early-stage cervical cancer. J Gynecol Oncol. 2014; 25(1):9–13. https://doi.org/10.3802/jgo.2014.25.1.9.

11. Diaz JP, Sonoda Y, Leitao MM, Zivanovic O, Brown CL, Chi DS, et al. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol Oncol. 2008; 111(2):255–260. https://doi.org/10.1016/j.ygyno.2008.07.014.

12. Marchiole P, Benchaib M, Buenerd A, Lazlo E, Dargent D, Mathevet P. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol. 2007; 106(1):132–141. https://doi.org/10.1016/j.ygyno.2007.03.009.

13. Smith ES, Moon AS, O'Hanlon R, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, et al. Radical trachelectomy for the treatment of early-stage cervical cancer: a systematic review. Obstet Gynecol. 2020; 136(3):533–542. https://doi.org/10.1097/AOG.0000000000003952.

14. Bentivegna E, Maulard A, Pautier P, Chargari C, Gouy S, Morice P. Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature. Fertil Steril. 2016; 106(5):1195–1211.e5. https://doi.org/10.1016/j.fertnstert.2016.06.032.

15. Bentivegna E, Gouy S, Maulard A, Chargari C, Leary A, Morice P. Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review. Lancet Oncol. 2016; 17(6):e240–e253. https://doi.org/10.1016/S1470-2045(16)30032-8.

16. Burbano J, Heredia F, Sanabria D, Ardila EG, Viveros-Carreño D, Rodriguez J. Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes. Int J Gynecol Cancer. 2021; 31(3):387–398. https://doi.org/10.1136/ijgc-2020-001765.

17. Raju SK, Papadopoulos AJ, Montalto SA, Coutts M, Culora G, Kodampur M, et al. Fertility-sparing surgery for early cervical cancer-approach to less radical surgery. Int J Gynecol Cancer. 2012; 22(2):311–317. https://doi.org/10.1097/IGC.0b013e3182370f51.

18. Salvo G, Ramirez PT, Leitao M, Cibula D, Fotopoulou C, Kucukmetin A, et al. International radical trachelectomy assessment: IRTA study. Int J Gynecol Cancer. 2019; 29(3):635–638. https://doi.org/10.1136/ijgc-2019-000273.

19. Lucchini SM, Esteban A, Nigra MA, Palacios AT, Alzate-Granados JP, Borla HF. Updates on conservative management of endometrial cancer in patients younger than 45 years. Gynecol Oncol. 2021; 161(3):802–809. https://doi.org/10.1016/j.ygyno.2021.04.017.

20. Park JY, Nam JH. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer. Oncologist. 2015; 20(3):270–278. https://doi.org/10.1634/theoncologist.2013-0445.

21. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: uterine neoplasms version 3.2021 [Internet]. Plymouth Meeting (PA): Author; 2021 [cited 2021 Jun 8]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf .

22. Gallos ID, Yap J, Rajkhowa M, Luesley DM, Coomarasamy A, Gupta JK. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol. 2012; 207(4):266.e1-12. https://doi.org/10.1016/j.ajog.2012.08.011.

23. Park JY, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, et al. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer. 2013; 49(4):868–874. https://doi.org/10.1016/j.ejca.2012.09.017.

24. Park JY, Seong SJ, Kim TJ, Kim JW, Kim SM, Bae DC, et al. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol. 2013; 121(1):136–142. https://doi.org/10.1097/aog.0b013e31827a0643.

25. De Marzi P, Bergamini A, Luchini S, Petrone M, Taccagni GL, Mangili G, et al. Hysteroscopic resection in fertility-sparing surgery for atypical hyperplasia and endometrial cancer: safety and efficacy. J Minim Invasive Gynecol. 2015; 22(7):1178–1182. https://doi.org/10.1016/j.jmig.2015.06.004.

26. Obermair A, Baxter E, Brennan DJ, McAlpine JN, Muellerer JJ, Amant F, et al. Fertility-sparing treatment in early endometrial cancer: current state and future strategies. Obstet Gynecol Sci. 2020; 63(4):417–431. https://doi.org/10.5468/ogs.19169.

27. Nam JH, Park JY. Fertility-sparing surgery for young women with early-stage epithelial ovarian cancer. Gynecol Obstet Invest. 2013; 76(1):14–24. https://doi.org/10.1159/000350797.

28. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: ovarian cancer version 1.2021 [Internet]. Plymouth Meeting (PA): Author; 2021 [cited 2021 Jun 8]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf.

29. Crafton SM, Cohn DE, Llamocca EN, Louden E, Rhoades J, Felix AS. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries. Cancer. 2020; 126(6):1217–1224. https://doi.org/10.1002/cncr.32620.

30. Melamed A, Rizzo AE, Nitecki R, Gockley AA, Bregar AJ, Schorge JO, et al. All-cause mortality after fertility-sparing surgery for stage i epithelial ovarian cancer. Obstet Gynecol. 2017; 130(1):71–79. https://doi.org/10.1097/AOG.0000000000002102.

31. Dolmans MM, Manavella DD. Recent advances in fertility preservation. J Obstet Gynaecol Res. 2019; 45(2):266–279. https://doi.org/10.1111/jog.13818.

32. Lee S, Ozkavukcu S, Ku SY. Current and future perspectives for improving ovarian tissue cryopreservation and transplantation outcomes for cancer patients. Reprod Sci. 2021; 28(6):1746–1758. https://doi.org/10.1007/s43032-021-00517-2.